Immedica Pharma US Inc.

États‑Unis d’Amérique

 
Quantité totale PI 30
Rang # Quantité totale PI 48 369
Note d'activité PI 2,1/5.0    18
Rang # Activité PI 46 599

Brevets

Marques

30 0
0 0
0 0
0
 
Dernier brevet 2025 - Ganaxolone for use in treating g...
Premier brevet 2006 - Liquid ganaxolone formulations a...

Derniers inventions, produits et services

2024 Invention Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders. The disclosure ...
Invention Prodrugs of ganaxolone. This disclosure relates to ganaxolone derivatives, as well as methods of...
Invention Ganaxolone for use in treatment of super refractory status epilepticus. This invention relates t...
Invention Ganaxolone for use in treatment of established status epilepticus. This invention relates to met...
Invention Ganaxolone for use in treating genetic epileptic disorders. The disclosure provides a method of ...
Invention Ganaxolone for use in treating tuberous sclerosis complex. The disclosure to methods for treatin...
2023 Invention Use of ganaxolone in treating an epilepsy disorder. The disclosure to methods for treating seizu...
Invention Ganaxolone for use in treating tuberous sclerosis complex. The disclosure to methods for treating...
Invention Injectable neurosteroid formulations containing nanoparticles. The disclosure provides an inject...
2020 Invention Methods of treating certain depressive disorders and delirium tremens. The disclosure provides a ...
2019 Invention Ganaxolone for use in prophylaxis and treatment of postpartum depression. Uses of ganaxolone in p...
2018 Invention Method of treatment using nanoparticulate ganaxolone formulations. In certain embodiments, the in...
2016 Invention Injectable neurosteroid formulations containing nanoparticles. The disclosure provides an injecta...
2015 Invention Solid ganaxolone compositions and methods for the making and use thereof. In certain embodiments,...
2013 Invention Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof. Di...
2012 Invention Solid ganaxolone formulations and methods for the making and use thereof. In certain embodiments,...
Invention Liquid ganaxolone formulations and methods for the making and use thereof. In certain embodiments...
2010 Invention Method for making 3α-hydroxy, 3β- substituted-5α-pregnan-20-ones. Applicants have discovered a me...